Record quarter for Allergan
Wednesday, November 12 2014 | 00 h 00 min | Financial News
In the third quarter of 2014, Allergan posted its strongest sales increase in the company’s history.
Allergan’s sales were CA$2 billion in the third quarter, up by 17.2% compared with the same period in 2013. Earnings totalled CA$350 million.
Pharmaceutical eyecare products (including Refresh and Restasis) showed a 14.2% sales increase to CA$915 million.
Allergan could not miss out on trumpeting its success, and perhaps it was thumbing its nose at Valeant. The latter is attempting to acquire Allergan and recently boasted its… second best quarter ever (see news clip from October 30).
For more information: http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=878172
